Pharmaceutical / Drug Definition :
Selectively inhibits DNA synthesis by disrupting DNA replication and transcription and suppressing protein synthesis, causing bacterial cell death
FDA Label Requirements and Exceptions
Moxifloxacin Hydrochloride
FDA Import Information
Moxifloxacin Hydrochloride
FDA Detentions
Moxifloxacin Hydrochloride (Moxifloxacin Hydrochloride Entry Refusal)
General U.S. Food and Drug Administration Guidelines for:
- Manufacturers Moxifloxacin Hydrochloride (Moxifloxacin Hydrochloride Suppliers)
- Processors Moxifloxacin Hydrochloride
- Repackers Moxifloxacin Hydrochloride
- Relabelers Moxifloxacin Hydrochloride
- Exporters Moxifloxacin Hydrochloride
- Importers Moxifloxacin Hydrochloride
For more information about Moxifloxacin Hydrochloride, simply click below:
U.S. FDA Regulations:
U.S. FDA Regulation: 21 C.F.R. Part 207
Registrar Corp assists businesses with U.S. FDA compliance. Certificates of Registration issued by Registrar Corp provide confirmation to industry that you are fulfilling U.S. FDA registration requirements. U.S. FDA does not issue or recognize Certificates of Registration. Registrar Corp is not affiliated with the U.S. Food and Drug Administration.
